FISH (fluroescence in situ hybridisation) offers fast way to check for genetic defects
This article was originally published in Clinica
Fluorescence in situ hybridisation (FISH) is superior to the conventional method of prenatal screening for genetic abnormalities, when a rapid result is needed, say German geneticists.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.